Genetic and environmental risk factors in Parkinson's disease (Q47938136)

6 February 2018

review article

1 reference

title

Genetic and environmental risk factors in Parkinson's disease (English)

1 reference

6 February 2018

1 reference

Veldman BA

1

1 reference

6 February 2018

Wijn AM

2

1 reference

6 February 2018

Knoers N

3

1 reference

6 February 2018

Praamstra P

4

1 reference

6 February 2018

Horstink MW

5

1 reference

6 February 2018

publication date

1 March 1998

1 reference

6 February 2018

Clinical Neurology and Neurosurgery

published in

1 reference

6 February 2018

volume

100

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

15-26

1 reference

6 February 2018

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

1 reference

7 January 2021

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Parkinsonism-plus syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Aging and Extrapyramidal Function

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Striatal dopamine deficiency in Parkinson's disease: role of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Xenobiotic metabolism in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Abnormal liver enzyme-mediated metabolism in Parkinson's disease: a second look

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Mutant debrisoquine hydroxylation genes in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Environmental risk factors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

The role of environmental toxins in the etiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Environmental factors in the etiology of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Environmental factors and Parkinson's disease: a case-control study in China

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Clustering of Parkinson's disease points to environmental etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Is Parkinson's disease acquired? Evidence from a geographic comparison with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Birthplace as a risk factor in motor neurone disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

The geographic distribution of Parkinson's disease mortality in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

A case-control study of Parkinson's disease in a horticultural region of British Columbia

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: Door-to-door community studies

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Parkinson's disease in a nationwide twin cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Parkinson's disease in 65 pairs of twins and in a set of quadruplets

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

A case-control study of twin pairs discordant for Parkinson's disease: a search for environmental risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Twin study of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Parkinson's disease in twins

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Parkinson's disease in twins

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Twin studies and the genetics of Parkinson's disease--a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Prion analogues and twin studies in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Parkinson's disease in twins studied with 18F-dopa and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Parkinson's disease: a test of the multifactorial etiologic hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Environmental risk factors in siblings with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Risk factors for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

On heredity, twins, and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

A clinical genetic study of Parkinson's disease: evidence for dominant transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Familial Parkinson's disease: a clinical genetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Genes and parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Increased risk of Parkinson's disease in parents and siblings of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Risk of Parkinson's disease among first-degree relatives: A community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

A large kindred with autosomal dominant Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Autosomal dominant Lewy body parkinsonism in a four-generation family

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Familial parkinsonism with depression: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

A clinical and genetic study of familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

A clinical and genetic study of familial cases of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Clinical genetic analysis of Parkinson's disease in the Contursi kindred

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

α-synuclein—a link between Parkinson and Alzheimer diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Genetic Complexity and Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Analysis of the alpha-synuclein G209A mutation in familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Origin and functional consequences of the complex I defect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Mitochondrial DNA polymorphisms in pathologically proven Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Mitochondrial DNA analysis in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Point mutations of mitochondrial genome in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Maternal inheritance in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Absence of mutations in superoxide dismutase and catalase genes in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Sequence of the superoxide dismutase 1 (SOD 1) gene in familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13?

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Association of a monoamine oxidase B allele with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Prevalence of Parkinson's disease in the elderly: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Worldwide occurrence of Parkinson's disease: an updated review

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

How far are we in understanding the cause of Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

High prevalence of Parkinson's disease in the Faroe Islands

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Incidental Lewy body disease in black Africans

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Epidemiology of parkinsonism: Incidence, classification, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Two decades of increasing mortality from Parkinson's disease among the US elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Peripherally induced tremor and parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Trauma as an etiology of parkinsonism: a historical review of the concept

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Posttraumatic movement disorders: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Incidence and risk factors of Parkinson's disease in The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Risk-factors for Parkinson's disease: case-control study in the province of Cáceres, Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Brain injury and neurologic sequelae: a cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Environmental antecedents of young-onset Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Parkinson's disease: a case-control study of occupational and environmental risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Nicotine exposure and Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Parkinson's disease and the environment in early life.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Smoking and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Environmental risk factors and Parkinson's disease: a case-control study in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Cigarette smoking and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Inhibition of monoamine oxidase B in the brains of smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Monoamine oxidase B, smoking, and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Hypothesis: a nicotine-dopamine interaction linking smoking with Parkinson's disease and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Smoking and Parkinson's disease. Search for a dose-response relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Epidemiologic study of Parkinson's disease in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

The "protective" influence of cigarette smoking on Alzheimer's and Parkinson's diseases. Quagmire or opportunity for neuroepidemiology?

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Nicotine activates and desensitizes midbrain dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Case-control study of early life dietary factors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Follow-up study of early-life protective and risk factors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Dietary antioxidants and Parkinson disease. The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa. Parkinson Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Serum levels of ascorbic acid (vitamin C) in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Serum levels of vitamin A in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Parkinson's disease and exposure to rural environmental factors: a population based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Exposure to well water and pesticides in Parkinson's disease: a case-control study in the Madrid area

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Clustering of Parkinson's disease in southern Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Predicting Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Paraquat and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Paraquat and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Parkinson's disease and exposure to agricultural work and pesticide chemicals

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Heavy metals and the etiology of Parkinson's disease and other movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

New insights into the cause of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

An introduction to the free radical hypothesis in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Complex I, iron, and ferritin in Parkinson's disease substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Manganism and idiopathic parkinsonism: similarities and differences

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Occupational exposures to metals as risk factors for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Parkinson's disease mortality and the industrial use of heavy metals in Michigan

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Serum levels of zinc and copper in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

A case control study of CSF copper, iron and manganese in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Parkinsonism associated with calcium channel blockers: a prospective follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Side-Effects: Mercury Contribution to Body Burden From Dental Amalgam

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Does mercury from amalgam restorations constitute a health hazard?

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

ENCEPHALITIS AND PARKINSONISM

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

COHORT ANALYSIS OF PARKINSON'S SYNDROME: EVIDENCE FOR A SINGLE ETIOLOGY RELATED TO SUBCLINICAL INFECTION ABOUT 1920.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Postencephalitic stereotyped involuntary movements responsive to L-Dopa

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Encephalitis lethargica-like illness in a five-year-old

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

No viral antigens detected in brain tissue from a case of acute encephalitis lethargica and another case of post-encephalitic parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

ENCEPHALITIS LETHARGICA

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

The substantia nigra is a major target for neurovirulent influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Measles infection and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Sequelae of western equine encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Neurodegenerative diseases and risk factors: a literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Viral Antibodies in Serum and CSF of Parkinsonian Patients and Controls

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Viral Antibodies in the Sera from Patients with Parkinson Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Aetiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Symptoms and duration of the prodromal phase in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Pathophysiology of movement disorders studied using PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Effects of agricultural work and other proxy-derived case-control data on Parkinson's disease risk estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

A comparison of clinical and pathological features of young- and old-onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

Young-onset Parkinson's disease: a clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900009-2

7 January 2021

10.1016/S0303-8467(98)00009-2

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018